<back

Rational Drug Design

Philip T. Pienkos, Ph.D.
Research Director, Molecular Logix, Inc.

Date/Time:
Tuesday, February 3, 2004
7:00 a.m. - 8:30 a.m.

Location:
Crowne Plaza Hotel, 6701 South Main St. (713) 797-1110
Map and Driving Information

Molecular LogiX, Inc. has a unique repertoire of proprietary tools and capabilities to radically shorten the drug development timeline. The Company is in the business of discovering, developing and ultimately selling proprietary drug candidates to feed the pharmaceutical developmental pipeline. This can be accomplished in remarkably short timeframes by modifying established targets and/or sub-optimal drugs, thus extending existing intellectual property and creating entirely new IP. The Company is utilizing proprietary molecular modeling technologies, licensed from the Baylor College of Medicine and elsewhere, to identify sensitive regions in target proteins and to predict modifications that will lead to improved therapeutic properties. These predictions are tested in the laboratories of MLX and our collaborators. The resulting "optimized lead candidates" are readily patented and can be ready for pre-clinical development in only 12-18 months. The Company intends to sell these drug leads to larger biotechnology and pharmaceutical companies.

Dr. Pienkos earned his undergraduate degree in Biology at University of Illinois , and a Ph.D. in Molecular Biology at University of Wisconsin . He performed postdoctoral work at University of Texas in Austin . Dr. Pienkos has been involved in biotechnology for over 20 years, first as a Senior Research Scientist working on antimicrobial screen development at Lederle Labs (now Wyeth-Ayerst). He worked in the area of biocatalysis at Celanese Research Company and at Celgene Corp., where he was a founding scientist. He continued working in biocatalysis and fermentation process development when he became Research Director at Energy BioSystems in 1994. When Energy BioSystems became Enchira Biotechnology and changed its focus to protein engineering he was responsible for screen development and protein production. In 2003, he joined Molecular Logix as Research Director to set up the labs, build the research staff, initiate the research programs and help build the project portfolio.

Cost:
$15 - Members with online reservations
$20 - Members with no reservations or non-members with online reservations
$25 - Non-members with no reservations

Reservations:
Registration Closed

 

 

[return to top]